AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2018
Dec 21, 2018
33298_dirs_2018-12-21_8f4b5e28-6aea-48df-97c1-490215cf2847.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2018-12-19
Reporting Person: Schreiber Justin (Director, Chief Executive Officer, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-12-19 | Common Stock, par value $0.01 | P | 5000 | $0.1649 | Acquired | 3098299 | Indirect |
| 2018-12-19 | Common Stock, par value $0.01 | P | 16701 | $0.165 | Acquired | 3115000 | Indirect |
| 2018-12-20 | Common Stock, par value $0.01 | P | 20000 | $0.19 | Acquired | 3135000 | Indirect |
| 2018-12-21 | Common Stock, par value $0.01 | P | 10000 | $0.185 | Acquired | 3145000 | Indirect |
Footnotes
F1: These shares were purchased on the open market.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17